Articles Medicine and Society Aug 2024 Can Medical-Legal Partnerships Do More to Advance Reproductive Justice After Dobbs? Medha Devanagondi Makhlouf, JD and Natasha Rappazzo MLPs have been overlooked as a strategy to advance reproductive health and justice. AMA J Ethics. 2024;26(8):E655-664. doi: 10.1001/amajethics.2024.655. Case and Commentary Aug 2024 What Should Clinicians in Organizations Without Established MLP Programs Do When Their Patients Need Lawyers to Meet Their Health Needs? Dinushika Mohottige, MD, MPH, Karina Albistegui Adler, JD, Allison Charney, JD, and Lilia Cervantes, MD, MSc Undocumented people in the US face legal and structural barriers to health care services, including for kidney failure. AMA J Ethics. 2024;26(8):E605-615. doi: 10.1001/amajethics.2024.605. Policy Forum Aug 2024 Why MLP Legal Care Should Be Financed as Health Care William M. Sage, MD, JD and Keegan D. Warren, JD, LLM Expanding MLPs’ positive health impact requires secure funding. AMA J Ethics. 2024;26(8):E640-647. doi: 10.1001/amajethics.2024.640. From the Editor Aug 2024 Medical-Legal Partnerships and the Future of Health Care Jin K. Park Integrating health care service delivery with illness and injury prevention and broader goals of social justice is a problem MLPs can help navigate. AMA J Ethics. 2024;26(8):E593-595. doi: 10.1001/amajethics.2024.593. In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024;26(7):E534-545. doi: 10.1001/amajethics.2024.534. History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580. Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. From the Editor Jul 2024 Why Harm Reduction and Equity Are Ethical Imperatives in Opioid Use Disorder Care Jeremy Weleff, DO American OUD care has generated deaths and discriminatory policies that need remediation. AMA J Ethics. 2024;26(7):E509-511. doi: 10.1001/amajethics.2024.509. Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024;26(7):E546-550. doi: 10.1001/amajethics.2024.546. Pagination First page « First Previous page ‹ Prev … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last »
Medicine and Society Aug 2024 Can Medical-Legal Partnerships Do More to Advance Reproductive Justice After Dobbs? Medha Devanagondi Makhlouf, JD and Natasha Rappazzo MLPs have been overlooked as a strategy to advance reproductive health and justice. AMA J Ethics. 2024;26(8):E655-664. doi: 10.1001/amajethics.2024.655.
Case and Commentary Aug 2024 What Should Clinicians in Organizations Without Established MLP Programs Do When Their Patients Need Lawyers to Meet Their Health Needs? Dinushika Mohottige, MD, MPH, Karina Albistegui Adler, JD, Allison Charney, JD, and Lilia Cervantes, MD, MSc Undocumented people in the US face legal and structural barriers to health care services, including for kidney failure. AMA J Ethics. 2024;26(8):E605-615. doi: 10.1001/amajethics.2024.605.
Policy Forum Aug 2024 Why MLP Legal Care Should Be Financed as Health Care William M. Sage, MD, JD and Keegan D. Warren, JD, LLM Expanding MLPs’ positive health impact requires secure funding. AMA J Ethics. 2024;26(8):E640-647. doi: 10.1001/amajethics.2024.640.
From the Editor Aug 2024 Medical-Legal Partnerships and the Future of Health Care Jin K. Park Integrating health care service delivery with illness and injury prevention and broader goals of social justice is a problem MLPs can help navigate. AMA J Ethics. 2024;26(8):E593-595. doi: 10.1001/amajethics.2024.593.
In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024;26(7):E534-545. doi: 10.1001/amajethics.2024.534.
History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580.
Case and Commentary Jul 2024 When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond? Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements. AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
From the Editor Jul 2024 Why Harm Reduction and Equity Are Ethical Imperatives in Opioid Use Disorder Care Jeremy Weleff, DO American OUD care has generated deaths and discriminatory policies that need remediation. AMA J Ethics. 2024;26(7):E509-511. doi: 10.1001/amajethics.2024.509.
Health Law Jul 2024 What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis? Maura McGinnity Some US localities are trying interventions modeled on international approaches to decriminalization. AMA J Ethics. 2024;26(7):E546-550. doi: 10.1001/amajethics.2024.546.